176 related articles for article (PubMed ID: 8747756)
1. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal.
Vaupel DB; Kimes AS; London ED
Psychopharmacology (Berl); 1995 Apr; 118(4):361-8. PubMed ID: 7568621
[TBL] [Abstract][Full Text] [Related]
3. The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
Zarrindast MR; Homayoun H; Khavandgar S; Fayaz-Dastgerdi M; Fayaz-Dastgerdi M
Behav Pharmacol; 2002 Mar; 13(2):117-25. PubMed ID: 11981224
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Mori T; Ito S; Matsubayashi K; Sawaguchi T
Behav Pharmacol; 2007 Dec; 18(8):725-9. PubMed ID: 17989510
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
London ED; Kimes AS; Vaupel DB
NIDA Res Monogr; 1995; 147():170-81. PubMed ID: 8742786
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.
Pasternak GW; Kolesnikov YA; Babey AM
Neuropsychopharmacology; 1995 Dec; 13(4):309-13. PubMed ID: 8747755
[TBL] [Abstract][Full Text] [Related]
7. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy.
Vaupel DB; Kimes AS; London ED
Eur J Pharmacol; 1997 Apr; 324(1):11-20. PubMed ID: 9137908
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
Hall S; Milne B; Jhamandas K
Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.
Makuch W; Mika J; Rojewska E; Zychowska M; Przewlocka B
Neuropharmacology; 2013 Dec; 75():445-57. PubMed ID: 24035921
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
Kimes AS; Vaupel DB; London ED
Psychopharmacology (Berl); 1993; 112(4):521-4. PubMed ID: 7532866
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.
Pineda J; Torrecilla M; Martín-Ruiz R; Ugedo L
Neuropharmacology; 1998 Jun; 37(6):759-67. PubMed ID: 9707290
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
13. Role of the nitric-oxide synthase isoforms during morphine-induced hyperthermia in rats.
Benamar K; Yondorf MZ; Kon D; Geller EB; Adler MW
J Pharmacol Exp Ther; 2003 Oct; 307(1):219-22. PubMed ID: 12954818
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.
Adams ML; Kalicki JM; Meyer ER; Cicero TJ
Life Sci; 1993; 52(22):PL245-9. PubMed ID: 7684108
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats.
Uzbay IT; Erden BF; Tapanyigit EE; Kayaalp SO
Life Sci; 1997; 61(22):2197-209. PubMed ID: 9393939
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice.
Ozek M; Uresin Y; Güngör M
Life Sci; 2003 Mar; 72(17):1943-51. PubMed ID: 12597993
[TBL] [Abstract][Full Text] [Related]
17. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
Herman BH; Vocci F; Bridge P
Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
[TBL] [Abstract][Full Text] [Related]
18. Effect of spinal infusion of L-NAME, a nitric oxide synthase inhibitor, on spinal tolerance and dependence induced by chronic intrathecal morphine in the rat.
Dunbar S; Yaksh TL
Neurosci Lett; 1996 Mar; 207(1):33-6. PubMed ID: 8710203
[TBL] [Abstract][Full Text] [Related]
19. The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons.
Bull PM; Ludwig M; Blackburn-Munro GJ; Delgado-Cohen H; Brown CH; Russell JA
Eur J Neurosci; 2003 Nov; 18(9):2545-51. PubMed ID: 14622155
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Neurosci Lett; 1993 Nov; 162(1-2):97-100. PubMed ID: 7510058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
